Literature DB >> 27434440

Improving Outcomes for Persons With Opioid Use Disorders: Buprenorphine Implants to Improve Adherence and Access to Care.

Wilson M Compton1, Nora D Volkow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27434440     DOI： 10.1001/jama.2016.8897

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Sex and heredity are determinants of drug intake in a novel model of rat oral oxycodone self-administration.

Authors:  Burt M Sharp; Xinyu Fan; Eva E Redei; Megan K Mulligan; Hao Chen
Journal:  Genes Brain Behav       Date:  2021-09-16       Impact factor: 3.449

Review 2.  New developments in managing opioid addiction: impact of a subdermal buprenorphine implant.

Authors:  MariaLisa Itzoe; Michael Guarnieri
Journal:  Drug Des Devel Ther       Date:  2017-05-10       Impact factor: 4.162

Review 3.  Advances in the delivery of buprenorphine for opioid dependence.

Authors:  Richard N Rosenthal; Viral V Goradia
Journal:  Drug Des Devel Ther       Date:  2017-08-28       Impact factor: 4.162

4.  Electrostatically gated nanofluidic membrane for ultra-low power controlled drug delivery.

Authors:  Nicola Di Trani; Antonia Silvestri; Antons Sizovs; Yu Wang; Donald R Erm; Danilo Demarchi; Xuewu Liu; Alessandro Grattoni
Journal:  Lab Chip       Date:  2020-05-05       Impact factor: 6.799

5.  Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.

Authors:  Theresa Winhusen; Michelle Lofwall; Hendrée E Jones; Christine Wilder; Robert Lindblad; Davida M Schiff; Scott Wexelblatt; Stephanie Merhar; Sean M Murphy; Shelly F Greenfield; Mishka Terplan; Elisha M Wachman; Frankie Kropp; Jeff Theobald; Mitra Lewis; Abigail G Matthews; Connie Guille; Michael Silverstein; Carmen Rosa
Journal:  Contemp Clin Trials       Date:  2020-04-27       Impact factor: 2.226
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.